Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
1(7%)
Results Posted
60%(6 trials)
Terminated
3(21%)

Phase Distribution

Ph not_applicable
4
29%
Ph phase_3
1
7%
Ph phase_1
3
21%
Ph phase_2
5
36%

Phase Distribution

3

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
3(23.1%)
Phase 2Efficacy & side effects
5(38.5%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
4(30.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(10)
Terminated(3)

Detailed Status

Completed10
Terminated3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
76.9%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (23.1%)
Phase 25 (38.5%)
Phase 31 (7.7%)
N/A4 (30.8%)

Trials by Status

terminated321%
active_not_recruiting17%
completed1071%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
14